Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Biochim Biophys Acta. 2014 Mar 12;1841(6):880–887. doi: 10.1016/j.bbalip.2014.03.001

Figure 3.

Figure 3

Rapamycin treatment of Acsl1H−/− mice attenuated the expression of pathologic hypertrophy markers. mRNA abundance of fetal gene markers, α-skeletal actin (α-Ska), B-type natriuretic peptide (Bnp), and atrial natriuretic factor (ANF) in ventricles from control and Acsl1H−/− mice treated with vehicle (Veh) or rapamycin (Rapa). The values are means plus SEMs (error bars). Values that are significantly different (p <0.05) from the values for the control are indicated by an asterisk. n = 3 per group.